MarzAA — clinical trials using this drug

Public-registry trials using MarzAA that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B	Catalyst Biosciences	Hemophilia A With Inhibitor	PHASE3	43

Registry history

First registered study	January 2018 — NCT03407651 (Catalyst Biosciences)
Registered studies matching this name	4 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Other Hemophilia A With Inhibitor drugs

← Eichor home · All tracked trials · Hemophilia A With Inhibitor studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →